Clinical Scorecard: Evaluation of Extreme Apical Biopsy Cores in Mid-Gland and Apex Intraprostatic Lesions

At a Glance

Key Highlights

• mpMRI and image-guided TBx have superior diagnostic accuracy compared to systematic biopsy alone.
• Extreme apical TBx sampling may add diagnostic value for csPCa detection in mid-apical lesions but is limited by anatomical and technical constraints.
• Optimizing TBx sampling strategy by adjusting number and location of cores can reduce morbidity without compromising csPCa detection.

Guideline-Based Recommendations

Diagnosis

• Use mpMRI with PI-RADS v2 scoring to identify PCa-suspicious lesions with score ≥ 3.
• Perform MRI/ultrasound fusion-guided targeted biopsy combined with ≥8-core systematic biopsy for accurate diagnosis.
• Assign clinical stage according to TNM 2002 system.

Management

• Administer oral antibiotic prophylaxis per European Association of Urology (EAU) guidelines before biopsy.
• Use peri-prostatic regional anesthesia during transrectal biopsy to reduce patient discomfort.
• Tailor TBx sampling strategy based on lesion anatomical location to minimize biopsy cores and morbidity.

Monitoring & Follow-up

• Record PSA levels prior to biopsy and monitor as part of clinical assessment.
• Document biopsy cores separately with histopathological interpretation by dedicated uropathologists.
• Use Gleason score ≥ 3+4 to define clinically significant prostate cancer.

Risks

• Consider morbidity related to biopsy near sphincter region, especially with extreme apical sampling.
• Limit number of biopsy cores to reduce procedural risks while maintaining diagnostic accuracy.

Patient & Prescribing Data

420 men with single mid-apical mpMRI PCa-suspicious lesions, median age 66 years, median PSA 7.7 ng/ml

Median 7 TBx cores per lesion with 44% csPCa detection; sampling strategy impacts detection rates and morbidity.

Clinical Best Practices

• Perform mpMRI according to ESUR and PI-RADS v2 guidelines using 3.0T MRI with phased-array coil.
• Ensure mpMRI readings by experienced uro-radiologists with access to clinical data and second readings if needed.
• Stratify biopsy cores by anatomical segment (mid-gland vs apical) to evaluate diagnostic yield and optimize sampling.
• Use combined TBx and SBx approach to maximize detection of clinically significant PCa.
• Adjust number of TBx cores per segment to balance diagnostic accuracy and procedural morbidity.

References

• European Association of Urology Guidelines on Prostate Cancer
• PI-RADS v2 Guidelines
• ESUR Guidelines for Prostate MRI